DI BELLA METHOD
>
DOCUMENTATION INDEX > MDB - Documents
[The scintigraphy of somatostatin receptors in the carcinoid tumor]
(30/05/2003)
Detail
Somatostatin receptor scintigraphy in the management of cerebral malignant ectomesenchymoma: a case report.
(30/05/2003)
Detail
Somatostatin controls Kaposi's sarcoma tumor growth through inhibition of angiogenesis.
(30/05/2003)
Detail
Somatostatin and somatostatin receptors in the diagnosis and treatment of gliomas.
(30/05/2003)
Detail
[Somatostatin and its receptors]
(30/05/2003)
Detail
Somatostatin and growth hormone-releasing hormone in normal and tumoral human breast tissue: endogenous content, in vitro pulsatile release, and regulation.
(30/05/2003)
Detail
Somatostatin and its analog lanreotide inhibit the proliferation of dispersed human non-functioning pituitary adenoma cells in vitro.
(30/05/2003)
Detail
Somatostatin induces migration of acute myeloid leukemia cells via activation of somatostatin receptor subtype 2.
(30/05/2003)
Detail
Somatostatin inhibits Akt phosphorylation and cell cycle entry, but not p42/p44 mitogen-activated protein (MAP) kinase activation in normal and tumoral pancreatic acinar cells.
(30/05/2003)
Detail
Somatostatin inhibits the production of vascular endothelial growth factor in human glioma cells.
(30/05/2003)
Detail
Somatostatin inhibits PDGF-stimulated Ras activation in human neuroblastoma cells.
(30/05/2003)
Detail
Single photon emission computed tomography procedure improves accuracy of somatostatin receptor scintigraphy in gastro-entero pancreatic tumours.
(30/05/2003)
Detail
Transcription of SST2 somatostatin receptor gene in human pancreatic cancer cells is altered by single nucleotide promoter polymorphism.
(30/05/2003)
Detail
Slow release lanreotide in combination with interferon-alpha2b in the treatment of symptomatic advanced medullary thyroid carcinoma.
(30/05/2003)
Detail
Localisation of mesenchymal tumours by somatostatin receptor imaging.
(30/05/2003)
Detail